Jupiter Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $172M | Buy |
1,357,537
+1,153,388
| +565% | +$152M | 0.85% | 18 |
|
|
2026
Q1 | $28.5M | Buy |
204,149
+189,239
| +1,269% | +$26.5M | 0.15% | 172 |
|
|
2025
Q4 | $1.83M | Buy |
14,910
+5,790
| +63% | +$704K | 0.01% | 326 |
|
|
2025
Q3 | $1.01M | Buy |
+9,120
| New | +$1.04M | 0.01% | 348 |
|
|
2025
Q2 | – | Sell |
-693,707
| Closed | -$77.7M | – | 467 |
|
|
2025
Q1 | $77.7M | Buy |
+693,707
| New | +$71.6M | 0.75% | 24 |
|
|
2024
Q2 | – | Sell |
-7,077
| Closed | -$518K | – | 418 |
|
|
2024
Q1 | $518K | Sell |
7,077
-90,520
| -93% | -$6.96M | ﹤0.01% | 389 |
|
|
2023
Q4 | $7.91M | Buy |
97,597
+55,112
| +130% | +$4.29M | 0.08% | 234 |
|
|
2023
Q3 | $3.18M | Buy |
42,485
+33,766
| +387% | +$2.6M | 0.04% | 287 |
|
|
2023
Q2 | $672K | Sell |
8,719
-350,236
| -98% | -$27.9M | 0.01% | 448 |
|
|
2023
Q1 | $29.8M | Buy |
+358,955
| New | +$29.7M | 0.41% | 74 |
|
|
2022
Q1 | – | Sell |
-3,161
| Closed | -$232K | – | 554 |
|
|
2021
Q4 | $232K | Buy |
+3,161
| New | +$218K | ﹤0.01% | 531 |
|
|
2021
Q1 | – | Sell |
-89,166
| Closed | -$5.19M | – | 596 |
|
|
2020
Q4 | $5.19M | Buy |
89,166
+29,690
| +50% | +$1.79M | 0.05% | 306 |
|
|
2020
Q3 | $3.75M | Buy |
+59,476
| New | +$4.12M | 0.04% | 333 |
|
|
2020
Q2 | – | Sell |
-67,612
| Closed | -$5.05M | – | 268 |
|
|
2020
Q1 | $5.05M | Sell |
67,612
-166,240
| -71% | -$11.5M | 0.22% | 117 |
|
|
2019
Q4 | $15.2M | Sell |
233,852
-17,537
| -7% | -$1.14M | 0.47% | 50 |
|
|
2019
Q3 | $15.9M | Sell |
251,389
-8,000
| -3% | -$523K | 0.52% | 46 |
|
|
2019
Q2 | $17.5M | Buy |
259,389
+15,692
| +6% | +$1.03M | 0.56% | 49 |
|
|
2019
Q1 | $15.8M | Buy |
243,697
+4,700
| +2% | +$312K | 0.51% | 51 |
|
|
2018
Q4 | $15M | Buy |
238,997
+22,600
| +10% | +$1.58M | 0.52% | 51 |
|
|
2018
Q3 | $16.6M | Buy |
216,397
+41,200
| +24% | +$3.11M | 0.47% | 61 |
|
|
2018
Q2 | $12.4M | Hold |
175,197
| – | – | 0.36% | 78 |
|
|
2018
Q1 | $13.2M | Buy |
175,197
+51,000
| +41% | +$4.05M | 0.4% | 71 |
|
|
2017
Q4 | $8.9M | Buy |
124,197
+36,597
| +42% | +$2.78M | 0.26% | 103 |
|
|
2017
Q3 | $7.1M | Buy |
87,600
+27,200
| +45% | +$2.08M | 0.24% | 96 |
|
|
2017
Q2 | $4.28M | Buy |
60,400
+19,300
| +47% | +$1.28M | 0.15% | 154 |
|
|
2017
Q1 | $2.79M | Buy |
+41,100
| New | +$2.89M | 0.1% | 190 |
|
Other funds holding GILD
Jupiter Asset Management's GILD Position: Q2 2026 in Review
Jupiter Asset Management increased its Gilead Sciences (GILD) stake by 565% in Q2 2026, buying an estimated $152M and bringing the position to 1,357,537 shares worth $172M. The position accounts for 0.85% of the portfolio, ranked #18.
Jupiter Asset Management first reported a position in GILD in Q1 2017 and has held it in 26 quarters since. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Jupiter Asset Management held 1,357,537 shares of Gilead Sciences worth $172M as of Q2 2026.
- Jupiter Asset Management bought 1,153,388 Gilead Sciences shares in Q2 2026, an estimated $152M.
- Gilead Sciences made up 0.85% of Jupiter Asset Management's portfolio in Q2 2026, its #18 holding.
- Jupiter Asset Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 26 quarters since.
- 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.